Avner Halperin is an entrepreneur, executive and researcher in AI, health, and technology policy. He serves as CEO of Sheba Impact – the commercialization and entrepreneurship arm of Sheba Medical Center. In this position, he leads the creation of dozens of breakthrough medical technology startups and the building of a vibrant startup ecosystem valued at over $5 Billion. In addition, he is the Chairman of the Board of EyeControl Ltd. - an AI based medical device company that won the Genesis Award for contribution to the battle again COVID-19, and he is Senior Fellow at the Harvard Kennedy School.

Previously, he was the founding CEO of EarlySense, that developed a contactless sensor which became the standard of care in over 1,000 US hospitals. Earlier, he was VP Marketing at Radcom (NASDAQ: RDCM) and R&D leader at Eldat Communications (acquired by Pricer).

Avner earned a M.Sc. in Applied Physics from Tel Aviv University and a MBA from MIT where he researched the operations of globally dispersed teams. He is a lecturer at Tel Aviv University where he teaches a course on AI Economics. In 2019, he gave a TED talk on AI in Healthcare. He is also an inventor with 34 US Patents.